Tri-substituted triazoles as potent non-nucleoside inhibitors of the HIV-1 reverse transcriptase
摘要:
A new series of 1,2,4-triazoles was synthesized and tested against several NNRTI-resistant HIV-1 isolates. Several of these compounds exhibited potent antiviral activities against efavirenz- and nevirapine-resistant viruses, containing K103N and/or Y181C mutations or Y188L mutation. Triazoles were first synthesized from commercially available substituted phenylthio-semicarbazides, then from isothiocyanates, and later by condensing the desired substituted anilines with thiosemicarbazones. (c) 2006 Elsevier Ltd. All rights reserved.
DOI:
10.1016/j.bmcl.2006.06.048
作为产物:
描述:
2,5-dimethyl-8-nitro-quinoline 在
镍氢气 、 crude mixture 、 正己烷 作用下,
以
乙醇 为溶剂,
反应 18.0h,
以to give (1.5 g 88% yield) of the pure desired amine的产率得到2,5-dimethyl-[8]quinolylamine
Various carbonyl amides are employed in vitro and in vivo as non-nucleoside inhibitors of a reverse transcriptase, and particularly of HIV reverse transcriptase. Therefore, contemplated compounds may be employed in the treatment of HIV infected patients. Further contemplated aspects include pharmaceutical compositions comprising therapeutically effective amounts of contemplated compounds.
Various carbonyl amides are employed in vitro and in vivo as non-nucleoside inhibitors of a reverse transcriptase, and particularly of HIV reverse transcriptase. Therefore, contemplated compounds may be employed in the treatment of HIV infected patients. Further contemplated aspects include pharmaceutical compositions comprising therapeutically effective amounts of contemplated compounds.